In 2014, I founded New Frontier Data, an analytics and business intelligence reporting group dedicated to the global cannabis industry, after more than 20 years in finance, industry analytics, intelligence reporting and emerging markets. As such, I have had the privilege of following hemp’s emergence and evolution. Half a decade later, this robust, environmentally friendly, low -cost-to-produce plant has become one of the most diversely applied and globally significant natural resources in the world. Here is a look at its applications across several mature industries:

Laboratory evidence indicated that cannabidiol may reduce THC clearance, increasing plasma concentrations which may raise THC availability to receptors and enhance its effect in a dose-dependent manner.[28][29] In vitro, cannabidiol inhibited receptors affecting the activity of voltage-dependent sodium and potassium channels, which may affect neural activity.[30] A small clinical trial reported that CBD partially inhibited the CYP2C-catalyzed hydroxylation of THC to 11-OH-THC.[31]
Industrial hemp is from the plant species Cannabis sativa and has been used worldwide to produce a variety of industrial and consumer products. Hemp is a source of fiber and oilseed grown in more than 30 nations. In the United States production is controlled under drug enforcement laws. To produce industrial hemp in the United States the grower must obtain a permit from the Drug Enforcement Agency (DEA).
Going forward, another emerging trend among recreational users are wellness lifestyles built around cannabis. This is certainly part of the influence of California’s new recreational marijuana market, which went online January 1, 2018. California is already an epicenter for health and wellness lifestyles and fads. Expect to see more of the same now that cannabis is completely legal.
Indeed, hemp oil products have grown out of a market largely devoid of regulations or safety protocols. The state of the CBD industry harks back to the age of elixirs and potions hawked from covered wagons to the awed denizens of pioneer towns. There are no industrywide standards in place to ensure that CBD oils are consistently formulated batch-to-batch. There is no regulatory body screening products for pesticides, heavy metals, solvent residues, and other dangerous contaminants. The laboratories that companies contract to test their CBD products are themselves neither standardized nor consistently regulated. No medical research exists to recommend how much CBD a patient should take, nor is there detailed, reliable documentation of how CBD interacts with most epilepsy medications.

The most pressing need of the hemp industry in North America is for the breeding of more productive oilseed cultivars. At present, mainly European cultivars are available, of which very few are suitable for specialized oilseed production. More importantly, hempseed oil is not competitive, except in the novelty niche market, with the popular food oils. As argued above, to be competitive, hemp should produce approximately 2 t/ha; at present 1 t/ha is considered average to good production. Doubling the productive capacity of a conventional crop would normally be considered impossible, but it needs to be understood just how little hemp has been developed as an oilseed. There may not even be extant land races of the kind of hemp oilseed strains that were once grown in Russia, so that except for a very few very recent oilseed cultivars, there has been virtually no breeding of oilseed hemp. Contrarily, hemp has been selected for fiber to the point that some breeders consider its productivity in this respect has already been maximized. Fiber strains have been selected for low seed production, so that most hemp germplasm has certainly not been selected for oilseed characteristics. By contrast, drug varieties have been selected for very high yield of flowers, and accordingly produce very high yield of seeds. Drug varieties have been observed to produce more than a kilogram of seed per plant, so that a target yield of several tonnes per hectare is conceivable (Watson and Clarke 1997). Of course, the high THC in drug cultivars makes these a difficult source of germplasm. However, wild plants of C. sativa have naturally undergone selection for high seed productivity, and are a particularly important potential source of breeding germplasm.
The Gateway Hypothesis states that cannabis use increases the probability of trying "harder" drugs. The hypothesis has been hotly debated as it is regarded by some as the primary rationale for the United States prohibition on cannabis use.[249][250] A Pew Research Center poll found that political opposition to marijuana use was significantly associated with concerns about health effects and whether legalization would increase marijuana use by children.[251]
The scientific debate regarding taxonomy has had little effect on the terminology in widespread use among cultivators and users of drug-type Cannabis. Cannabis aficionados recognize three distinct types based on such factors as morphology, native range, aroma, and subjective psychoactive characteristics. Sativa is the most widespread variety, which is usually tall, laxly branched, and found in warm lowland regions. Indica designates shorter, bushier plants adapted to cooler climates and highland environments. Ruderalis is the informal name for the short plants that grow wild in Europe and Central Asia.